IDiyas

For the Inventor, By the Inventor

Cincinnati, OH, United States of America

Norbert L Wiech

USPTO Granted Patents = 13


Average Co-Inventor Count = 2.6

ph-index = 7

Forward Citations = 119(Granted Patents)


Company Filing History:

goldMedal9 out of 455 
 
Merrell Dow Pharmaceuticals
 patents
silverMedal4 out of 167 
 
Richardson-merrell Inc.
 patents

Years Active: 1976-1993

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents
1. 5198433 - Lactamimides as calcium antagonists (1993-03-30),
2. 5169096 - N-aralkyl-piperidine-methanol derivatives (1992-12-08),
3. 5158945 - Lactamimides as calcium antagonists (1992-10-27),
4. 5128337 - Lactamimides as calcium antagonists (1992-07-07),
5. 5082837 - Lactamimides as calcium antagonists (1992-01-21),
6. 5021428 - Novel chemical compounds for the prophylactic treatment of migraine (1991-06-04),
7. 5010072 - Lactamimides as calcium antagonists (1991-04-23),
8. 4912117 - Novel chemical compounds (1990-03-27),
9. 4783471 - N-aralkyl piperidine methanol derivatives and the uses thereof (1988-11-08),
10. 4310524 - TCA Composition and method for rapid onset antidepressant therapy (1982-01-12),
11. 4281006 - 2-(Diphenylalkylimino)piperidine-3-carboxanilides as inhibitors of (1981-07-28),
12. 4061746 - Lactamimide inhibitors of gastrointestinal hypersecretion (1977-12-06),
13. 3963701 - Substituted benzhydryl lactamimide derivatives (1976-06-15),

Title: Unveiling the Innovative Mind of Norbert L Wiech from Cincinnati, OH

Introduction:

Meet Norbert L Wiech, a prolific inventor hailing from Cincinnati, OH, who has made significant contributions to the field of pharmaceuticals with an impressive portfolio of 13 patents.

Latest Patents:

1. "Lactamimides as Calcium Antagonists": Wiech's groundbreaking discovery of certain lactamimide derivatives with potent calcium channel blocking activity has unveiled new possibilities in the realm of antihypertensive drugs.

2. "N-aralkyl-piperidine-methanol Derivatives": Through this invention, Wiech has introduced a novel class of compounds that act as selective inhibitors of serotonin binding at the 5HT.sub.2 receptor site, showcasing remarkable biochemical and pharmacological properties.

Career Highlights:

Wiech's journey to innovation includes pivotal roles at renowned pharmaceutical companies like Merrell Dow Pharmaceuticals and Richardson-Merrell Inc., where he honed his skills and expertise in the development of cutting-edge pharmaceutical solutions.

Collaborations:

Collaborating with esteemed colleagues such as Michael G Palfreyman and Hsien C Cheng, Wiech has fostered a culture of innovation and excellence, driving forward groundbreaking research and development in the pharmaceutical industry.

Conclusion:

In conclusion, Norbert L Wiech stands as a trailblazing inventor whose relentless pursuit of scientific excellence has led to groundbreaking discoveries in the realm of pharmaceuticals. His adeptness in patenting novel compounds underscores his commitment to shaping the future of healthcare through innovation and ingenuity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…